Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective.
暂无分享,去创建一个
[1] K. Mann,et al. The Association of Anticoagulant Protein Concentrations with Acute Myocardial Infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Trial , 2004, Journal of Thrombosis and Thrombolysis.
[2] S. Humphries,et al. In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[3] G. Bernard,et al. Activated protein C for severe sepsis. , 2002, The New England journal of medicine.
[4] P. Savage,et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study. , 2002, Diabetes.
[5] B. Nordestgaard,et al. Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. , 2002, Blood.
[6] M. Margaglione,et al. Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[7] T. Lüscher,et al. Statin Prevents Tissue Factor Expression in Human Endothelial Cells: Role of Rho/Rho-Kinase and Akt Pathways , 2002, Circulation.
[8] A. Folsom,et al. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. , 2002, Blood.
[9] A. Arnold,et al. No Association of Plasma Prothrombin Concentration or the G20210A Mutation with Incident Cardiovascular Disease , 2002, Thrombosis and Haemostasis.
[10] R. Virmani,et al. Traditional Risk Factors and the Incidence of Sudden Coronary Death With and Without Coronary Thrombosis in Blacks , 2002, Circulation.
[11] K. Takeda,et al. Thrombin Induces Interleukin-6 Expression Through the cAMP Response Element in Vascular Smooth Muscle Cells , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[12] G. Lowe,et al. Fibrin D-dimer, Markers of Coagulation Activation and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study , 2001, Thrombosis and Haemostasis.
[13] Peter Libby,et al. Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.
[14] R. Tracy. Is visceral adiposity the "enemy within"? , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[15] M. Runge,et al. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. , 2001, Circulation research.
[16] N Rifai,et al. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. , 2001, JAMA.
[17] J. Danesh,et al. Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.
[18] V. Fuster,et al. Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.
[19] V. Salomaa,et al. Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[20] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.
[21] G. Hansson. Immune mechanisms in atherosclerosis. , 1989, Arteriosclerosis, thrombosis, and vascular biology.
[22] P. Wahl,et al. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.
[23] J. Meigs,et al. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. , 2000, American journal of epidemiology.
[24] S. Haffner,et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.
[25] P. Pekala,et al. Tumor necrosis factor-alpha-induced insulin resistance in adipocytes. , 2000, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[26] S. Humphries,et al. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? , 2000, Atherosclerosis.
[27] P. Sakkinen,et al. Interleukin-6 exacerbates early atherosclerosis in mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[28] B. Sobel. Coronary Artery Disease and Fibrinolysis: From the Blood to the Vessel Wall , 1999, Thrombosis and Haemostasis.
[29] R. Tracy. Epidemiological Evidence for Inflammation in Cardiovascular Disease , 1999, Thrombosis and Haemostasis.
[30] C. Visser,et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? , 1999, Circulation.
[31] P. Savage,et al. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[32] G. Hotamisligil. The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .
[33] B. Sobel. Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox. , 1999, Circulation.
[34] Gerardo Heiss,et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.
[35] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[36] J. Yudkin. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? , 1999, Diabetes Care.
[37] S. Coppack,et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[38] G. Raghu,et al. α-Thrombin Inhibits Interleukin-6-Induced Stat3 Signaling and gp130 Gene Expression in Primary Cultures of Human Lung Fibroblasts , 1999 .
[39] A. Sharrett,et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[40] L. Kuller,et al. Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[41] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[42] P. Morange,et al. PAI-1, Obesity, and Insulin Resistance , 1999 .
[43] I. Kullo,et al. Vulnerable Plaque: Pathobiology and Clinical Implications , 1998, Annals of Internal Medicine.
[44] F. Burzotta,et al. The 4G/5G Polymorphism of PAI-1 Promoter Gene and the Risk of Myocardial Infarction: A Meta-analysis , 1998, Thrombosis and Haemostasis.
[45] J S Yudkin,et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.
[46] C. Thompson,et al. Tumor necrosis factor receptor-associated factors (TRAFs)--a family of adapter proteins that regulates life and death. , 1998, Genes & development.
[47] R. Bertina. The prothrombin 20210 G to A variation and thrombosis , 1998, Current opinion in hematology.
[48] M. Pfeffer,et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. , 1998, Circulation.
[49] V. Fuster,et al. Atherothrombosis: mechanisms and clinical therapeutic approaches , 1998, Vascular medicine.
[50] H. Lithell,et al. Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus , 1998 .
[51] M. Cushman,et al. Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort , 1998, Thrombosis and Haemostasis.
[52] F. Rosendaal,et al. Venous thrombosis--the interaction of genes and environment. , 1998, The New England journal of medicine.
[53] R Peto,et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. , 1998, JAMA.
[54] D. Loskutoff,et al. The adipocyte and hemostatic balance in obesity: studies of PAI-1. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[55] F. Neumann,et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[56] D. Schneider,et al. Dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. , 1997, Circulation.
[57] L. Kuller,et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[58] A. Folsom,et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. , 1997, Circulation.
[59] D Kromhout,et al. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. , 1997, European heart journal.
[60] T. Raghunathan,et al. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. , 1997, Blood.
[61] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[62] R. Tracy. Atherosclerosis, thrombosis and inflammation: a problem of linkage* , 1997 .
[63] M. Alessi,et al. Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. , 1996, Annals of medicine.
[64] D. Strachan,et al. C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.
[65] M. Nesheim,et al. Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*) , 1995, The Journal of Biological Chemistry.
[66] P. Edwards,et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.
[67] M. Runge,et al. Thrombin hypothesis of thrombus generation and vascular lesion formation. , 1995, The American journal of cardiology.
[68] R. Califf,et al. Acute Coronary Care In The Thrombolytic Era , 1995 .
[69] R. Puri,et al. Human Cytokines: Their Role in Disease and Therapy , 1995 .
[70] R. Krauss,et al. Multivariate analysis of the insulin resistance syndrome in women. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[71] P. Ridker,et al. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.
[72] Harry,et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. , 1993, Blood.
[73] C. Esmon. The protein C anticoagulant pathway. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[74] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[75] P. Pilch,et al. Insulin secretion and action and diabetes mellitus , 1992, Journal of cellular biochemistry.
[76] C. Esmon,et al. Inflammation and Coagulation: Linked Processes Potentially Regulated Through a Common Pathway Mediated by Protein C , 1991, Thrombosis and Haemostasis.
[77] T. Kooistra,et al. Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2 , 1988, Thrombosis and Haemostasis.
[78] R. D'Agostino,et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. , 1987, JAMA.
[79] M. Blombäck,et al. PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.
[80] S. Thompson,et al. HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY , 1986, The Lancet.
[81] M. Blombäck,et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.
[82] M. C. Stone,et al. Plasma fibrinogen--a major coronary risk factor. , 1985, The Journal of the Royal College of General Practitioners.
[83] J. Verheijen,et al. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. , 1985, Scandinavian journal of clinical and laboratory investigation.
[84] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[85] D. Ritchie,et al. Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[86] C. Mold,et al. C-reactive protein and the acute phase response. , 1982, Advances in internal medicine.
[87] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[88] S. Thompson,et al. HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.
[89] H. Keen,et al. Haemostatic variables associated with diabetes and its complications. , 1979, British medical journal.
[90] Oxon Dm. Obituary. Rupert Samuel Bruce Pearson. , 1974 .
[91] Maddocks Ac. Letter: Sterilisation of cardiac bioptome. , 1974 .